NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Dermatology/Gonorrhea and Chlamydia — Genital
    Gonorrhea and Chlamydia — Genital
    medium
    hand Dermatology

    A 24-year-old woman presents with cervical discharge and lower abdominal pain for 2 weeks. Cervical examination reveals mucopurulent discharge and cervical friability. She is suspected to have pelvic inflammatory disease (PID) secondary to chlamydial infection. Which investigation has the highest sensitivity for confirming *Chlamydia trachomatis* infection in this setting?

    A. Giemsa stain of endocervical smear for inclusion bodies
    B. Nucleic acid amplification test (NAAT) on endocervical swab or first-void urine
    C. Culture on McCoy cells
    D. Enzyme immunoassay (EIA) for chlamydial antigen on endocervical swab

    Explanation

    ## Investigation of Choice for Chlamydial PID ### Why NAAT is the Gold Standard **High-Yield:** NAAT (PCR, TMA, SDA) is the most sensitive (>95%) and specific (>99%) test for *Chlamydia trachomatis*. It is the recommended first-line investigation for suspected chlamydial infection, especially in the context of PID. **Key Point:** NAAT advantages in chlamydial PID: - Highest sensitivity (>95%) — detects both viable and non-viable organisms - Can be performed on multiple specimen types: endocervical swab, first-void urine, or vaginal swab - Rapid turnaround (24–48 hours) - Does not require viable organism or special culture conditions - Recommended by CDC, WHO, and Indian STI guidelines as the investigation of choice ### Comparison of Investigations for Chlamydia Detection | Investigation | Sensitivity | Specificity | Specimen Type | Speed | Clinical Use | |---|---|---|---|---|---| | **NAAT** | >95% | >99% | Cervical, urine, vaginal | 24–48 hrs | **Gold standard** | | EIA | 70–90% | 95–98% | Cervical, urethral | 2–4 hrs | Rapid screening; lower sensitivity | | Giemsa stain | 30–50% | 95% | Cervical | Immediate | Poor sensitivity; not recommended | | Culture (McCoy cells) | 70–85% | 100% | Cervical, urethral | 48–72 hrs | Slow; requires viable organisms; rarely used | ### Clinical Pearl **Warning:** Chlamydial PID is often asymptomatic or presents with subtle signs. NAAT on first-void urine is particularly useful in women who may not tolerate cervical swabbing, making it the most practical and sensitive choice for diagnosis. **Mnemonic:** **NAAT = Non-culture Amplification Assay Test** — the modern standard for chlamydia diagnosis, replacing culture and antigen detection. ### Why Other Tests Fail in PID EIA (antigen detection) has lower sensitivity than NAAT and may miss early or low-burden infections. Giemsa stain is insensitive (30–50%) and operator-dependent. Culture requires viable organisms and is rarely available in routine practice. [cite:Harrison 21e Ch 137; CDC STI Treatment Guidelines 2021] ![Gonorrhea and Chlamydia — Genital diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/15199.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Dermatology Questions